News
October 13, 2020
Secarna Pharmaceuticals and Denali Therapeutics enter into research and option agreement to develop novel antisense therapies in the field of neurodegenerative diseases
October 13, 2020
April 28, 2020
Secarna Pharmaceuticals enters into cooperation with Guangzhou’s Sun Yat-sen University to develop a treatment for SARS-CoV-2 viral infections
March 27, 2018
BIO-Europe Spring® 2018 / Secarna MD Jonas Renz on standing out in a crowd
March 27, 2018